相关实验视频

Updated: Jul 16, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

心肌缺血中缺铁:分子机制和治疗前景

Francesco Corradi¹, Gabriele Masini², Tonino Bucciarelli¹

¹Department of Medicine and Aging Sciences, "G. D'Annunzio" University of Chieti-Pescara, Via dei Vestini, 66100, Chieti, Italy.

Cardiovascular research

|September 18, 2023

概括

心肌缺铁 (MID),独立于全身缺铁或贫血,显著恶化心力衰竭的预后. 静脉注射铁可以预防严重的心脏功能障碍和心力衰竭患者的死亡率.

科学领域:

心脏病学心脏病学
铁的新陈代谢铁的新陈代谢
线粒体生物学线粒体生物学

背景情况:

系统性铁缺乏症 (SID) 恶化了心力衰竭 (HF) 的预后,即使没有贫血.
心肌铁缺乏症 (MID) 在严重的HF中很普遍,不论是SID还是贫血.
系统和心肌铁水平的相关性很差.

研究的目的:

审查将MID与HF预后和心肌缺血症联系在一起的证据.
探索MID加剧心脏功能障碍和损伤的分子机制.
突出铁代谢作为HF和缺血性心脏病的关键因素.

主要方法:

对心力衰竭和心肌缺血中铁缺乏症的临床-流行病学和实验研究的综述.
对MID对线粒体功能,心脏力学和对铁疗法的反应影响的数据分析.
讨论涉及MID相关心脏病理学的拟议分子途径.

主要成果:

在动物模型中,MID会导致严重的线粒体功能障碍,改变线粒体细胞吸收/生物发生,心脏机制受损和致命的心肌病,可通过静脉注射铁预防.
MID加剧了急性心肌缺血和后缺血重塑,静脉注射铁改善了结果.
有证据表明,MID通过包括HIF1-α激活,过载和NAD+耗尽在内的机制恶化缺血/再输损伤.

结论:

心肌铁状况,而不仅仅是系统性铁,对于HF预后和死亡率至关重要.
MID有助于不良的心脏重塑和缺血/再输液损伤.
准心肌铁代谢是心力衰竭和缺血性心脏病的潜在治疗策略.

关键词:

铁铁铁是什么意思铁铁铁缺血性心肌病症缺血性心肌病症心肌冬眠是指心肌的冬眠.心肌铁缺乏症是心肌铁缺乏症.心肌缺血是什么意思心肌缺血是什么意思系统性铁缺乏症是什么

更多相关视频

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

相关概念视频

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...